Xilio Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 08/14/2026 | 664.02 K | $6.36 M | 0.00% | 3.42% |
| ORBIMED ADVISORS LLC | 08/14/2026 | 592.30 K | $5.67 M | 100.00% | 3.05% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 08/14/2026 | 422.51 K | $4.05 M | 0.00% | 2.18% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 08/17/2026 | 225.99 K | $2.17 M | 252.22% | 1.16% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 178.52 K | $1.71 M | 44.36% | 0.92% |
| SIO CAPITAL MANAGEMENT, LLC | 08/14/2026 | 152.46 K | $1.46 M | 0.00% | 0.79% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 08/14/2026 | 111.54 K | $1.07 M | 100.00% | 0.57% |
| MERCK & CO., INC. | 08/07/2026 | 105.98 K | $1.02 M | 0.00% | 0.55% |
| RENAISSANCE TECHNOLOGIES LLC | 08/13/2026 | 64.15 K | $614.59 K | 29.43% | 0.33% |
| MORGAN STANLEY | 08/13/2026 | 56.95 K | $545.62 K | -0.94% | 0.29% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 39.06 K | $374.17 K | 5.00% | 0.20% |
| CITADEL ADVISORS LLC | 09/02/2026 | 25.95 K | $248.60 K | 100.00% | 0.13% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 22.59 K | $216.45 K | -20.65% | 0.12% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 08/14/2026 | 17.54 K | $168.07 K | 100.00% | 0.09% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 14.54 K | $139.33 K | 100.00% | 0.08% |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 08/14/2026 | 14.29 K | $136.85 K | 0.00% | 0.07% |
| GSA CAPITAL PARTNERS LLP | 08/06/2026 | 13.59 K | $130.00 K | -19.80% | 0.07% |
| STATE STREET CORP | 08/07/2026 | 13.31 K | $127.52 K | 0.00% | 0.07% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 08/14/2026 | 11.60 K | $111.13 K | 100.00% | 0.06% |
| BLACKROCK, INC. | 08/07/2026 | 8.76 K | $83.89 K | 100.00% | 0.05% |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 08/13/2026 | 714 | $6.84 K | 100.00% | 0.00% |
| SECURITY NATIONAL BANK OF SIOUX CITY IOWA /IA/ | 09/18/2026 | 321 | $3.08 K | 100.00% | 0.00% |
| BARCLAYS PLC | 08/14/2026 | 115 | $1.10 K | 100.00% | 0.00% |
| KEY FINANCIAL INC | 07/24/2026 | 59 | $565 | 0.00% | 0.00% |
| JONES FINANCIAL COMPANIES LLLP | 08/14/2026 | 29 | $262 | 100.00% | 0.00% |
| UBS GROUP AG | 08/13/2026 | 14 | $134 | -99.65% | 0.00% |
| JPMORGAN CHASE & CO | 08/12/2026 | 0 | $0 | -100.00% | 0.00% |
| FMR LLC | 08/13/2026 | 0 | $0 | -100.00% | 0.00% |
| ROYAL BANK OF CANADA | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| CALIGAN PARTNERS LP | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| VANGUARD GLOBAL ADVISERS, LLC | 08/13/2026 | 0 | $0 | -100.00% | 0.00% |
| GHISALLO CAPITAL MANAGEMENT LLC | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Xilio Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 41 institutional investors and hedge funds held shares of Xilio Therapeutics Inc. The most heavily invested institutionals were:
Bain Capital Life Sciences Investors, LLC: 664,021
ORBIMED ADVISORS LLC: 592,300
Frazier Life Sciences Management, L.P.: 422,505
Stonepine Capital Management, LLC: 225,994
VANGUARD CAPITAL MANAGEMENT LLC: 178,517
Sio Capital Management, LLC: 152,464
14.21% of Xilio Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 7.09 M shares in the last 24 months. This purchase volume represents approximately $3.83 M in transactions.